Product approvals

This undated image provided by AcelRx Pharmaceuticals shows the company's medication Dsuvia. On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. (Craig Sherod Photography/AcelRx Pharmaceuticals via AP)
November 02, 2018 - 11:10 am
TRENTON, N.J. (AP) — U.S. regulators have approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. The decision by the Food and Drug Administration on Friday came over objections from critics who fear the pill will be abused. In a statement, FDA...
Read More
October 19, 2018 - 5:12 am
LONDON (AP) — Europe's medicines regulator has recommended the approval of the first vaccine for dengue despite concerns about the vaccine's wide use and a lawsuit in the Philippines alleging it was linked to three deaths. The European Medicines Agency said Friday it had adopted a "positive opinion...
Read More
FILE - This Dec. 4, 2013 file photo shows vials of flavored liquid at a store selling electronic cigarettes and related items in Los Angeles. On Wednesday, Sept. 12, 2018, U.S. health officials said teenage use of e-cigarette has reached “epidemic” levels in the U.S. and are calling on the industry to address the problem or risk having their flavored products pulled off the market. (AP Photo/Reed Saxon, File)
September 12, 2018 - 11:53 am
WASHINGTON (AP) — U.S. health officials are sounding the alarm about teenage use of e-cigarettes, calling the problem an "epidemic" and ordering manufacturers to reverse the trend or risk having their flavored vaping products pulled from the market. The warning from the Food and Drug Administration...
Read More
FILE - This April 28, 2010, file photo shows the GlaxoSmithKline offices in London. On Friday, July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatment, to prevent relapses of malaria. (AP Photo/Kirsty Wigglesworth, File)
July 20, 2018 - 2:58 pm
U.S. regulators have approved a simpler, one-dose treatment to prevent relapses of malaria. Standard treatment takes two weeks and many patients don't finish taking all the doses. Malaria is caused by parasites that are spread through mosquito bites. The parasites can remain dormant in the liver...
Read More
FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The Food and Drug Administration is considering easing the process for drugmakers to get approval to sell some prescription medicines over the counter, a move to offer consumers convenience and lower prices. FDA Commissioner Dr. Scott Gottlieb said Tuesday, July 17, 2018 that the agency has developed tentative guidelines for drugmakers to do so, while maintaining safety standards. (AP Photo/Andrew Harnik, File)
July 17, 2018 - 10:08 am
U.S. regulators proposed new guidelines Tuesday to make it easier for some common medicines to be sold without a prescription — and more convenient for consumers to get them. The Food and Drug Administration is evaluating ways to make sure patients don't take an inappropriate over-the-counter drug...
Read More

Pages